|
1
|
Guggenheim DE and Shah MA: Gastric cancer
epidemiology and risk factors. J Surg Oncol. 107:230–236. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Nagini S: Carcinoma of the stomach: a
review of epidemiology, pathogenesis, molecular genetics and
chemoprevention. World J Gastrointest Oncol. 4:156–169. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Tan IB, Ng I, Tai WM and Tan P:
Understanding the genetic basis of gastric cancer: recent advances.
Expert Rev Gastroenterol Hepatol. 6:335–341. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kiechle FL and Zhang X: Apoptosis:
biochemical aspects and clinical implications. Clin Chim Acta.
326:27–45. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Schultz DR and Harrington WJ Jr:
Apoptosis: programmed cell death at a molecular level. Semin
Arthritis Rheum. 32:345–369. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chambers AF, Groom AC and MacDonald IC:
Dissemination and growth of cancer cells in metastatic sites. Nat
Rev Cancer. 2:563–572. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Brábek J, Mierke CT, Rösel D, Veselý P and
Fabry B: The role of the tissue microenvironment in the regulation
of cancer cell motility and invasion. Cell Commun Signal.
8:222010.PubMed/NCBI
|
|
8
|
Chaffer CL and Weinberg RA: A perspective
on cancer cell metastasis. Science. 331:1559–1564. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kenneth NS and Duckett CS: IAP proteins:
regulators of cell migration and development. Curr Opin Cell Biol.
24:871–875. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yan B: Research progress on Livin protein:
an inhibitor of apoptosis. Mol Cell Biochem. 357:39–45. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wang L, Zhang Q, Liu B, Han M and Shan B:
Challenge and promise: roles for Livin in progression and therapy
of cancer. Mol Cancer Ther. 7:3661–3669. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chang H and Schimmer AD: Livin/melanoma
inhibitor of apoptosis protein as a potential therapeutic target
for the treatment of malignancy. Mol Cancer Ther. 6:24–30. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Liu B, Han M, Wen JK and Wang L:
Livin/ML-IAP as a new target for cancer treatment. Cancer Lett.
250:168–176. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Gazzaniga P, Gradilone A, Giuliani L, et
al: Expression and prognostic significance of LIVIN, SURVIVIN and
other apoptosis-related genes in the progression of superficial
bladder cancer. Ann Oncol. 14:85–90. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hariu H, Hirohashi Y, Torigoe T, et al:
Aberrant expression and potency as a cancer immunotherapy target of
inhibitor of apoptosis protein family, Livin/ML-IAP in lung cancer.
Clin Cancer Res. 11:1000–1009. 2005.PubMed/NCBI
|
|
16
|
Kim DK, Alvarado CS, Abramowsky CR, et al:
Expression of inhibitor-of-apoptosis protein (IAP) livin by
neuroblastoma cells: correlation with prognostic factors and
outcome. Pediatr Devel Pathol. 8:621–629. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Xi RC, Biao WS and Gang ZZ: Significant
elevation of survivin and livin expression in human colorectal
cancer: inverse correlation between expression and overall
survival. Onkologie. 34:428–432. 2011. View Article : Google Scholar
|
|
18
|
Yagihashi A, Asanuma K, Tsuji N, Torigoe
T, Sato N, Hirata K and Watanabe N: Detection of anti-livin
antibody in gastrointestinal cancer patients. Clin Chem.
49:1206–1208. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Liang YZ, Fang TY, Xu HG and Zhuo ZQ:
Expression of CD44v6 and Livin in gastric cancer tissue. Chin Med J
(Engl). 125:3161–3165. 2012.PubMed/NCBI
|
|
20
|
Wang TS, Ding QQ, Guo RH, Shen H, Sun J,
Lu KH, You SH, Ge HM, Shu YQ and Liu P: Expression of livin in
gastric cancer and induction of apoptosis in SGC-7901 cells by
shRNA-mediated silencing of livin gene. Biomed Pharmacother.
64:333–338. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lauren P: The two histologic main types of
gastric carcinoma: diffuse and so-called intestinal-type carcinoma.
An attempt at a histo-clinical classification. Acta Pathol
Microbiol Scand. 64:31–49. 1965.PubMed/NCBI
|
|
22
|
Watanabe H, Jass JR and Sobin LH: WHO
International Histologic Classification of Tumors: Histologic
Typing of Oesophageal and Gastric Tumors. 2nd edition.
Springer-Verlag; Berlin: 1990
|
|
23
|
American Joint Committee on Cancer. AJCC
Cancer Staging Manual: Stomach. Lippincott-Raven; Philadelphia: pp.
71–76. 1997
|
|
24
|
Morgan DO: Principles of CDK regulation.
Nature. 374:131–134. 1995. View
Article : Google Scholar : PubMed/NCBI
|
|
25
|
Graña X and Reddy EP: Cell cycle control
in mammalian cells: role of cyclins, cyclin dependent kinases
(CDKs), growth suppressor genes and cyclin-dependent kinase
inhibitors (CKIs). Oncogene. 11:211–219. 1995.PubMed/NCBI
|
|
26
|
Tian Y, Wan H and Tan G: Cell
cycle-related kinase in carcinogenesis. Oncol Lett. 4:601–606.
2012.PubMed/NCBI
|
|
27
|
Curtin NJ: DNA repair dysregulation from
cancer driver to therapeutic target. Nat Rev Cancer. 12:801–817.
2012. View
Article : Google Scholar : PubMed/NCBI
|
|
28
|
Amoedo ND, El-Bacha T, Rodrigues MF and
Rumjanek FD: Cell cycle and energy metabolism in tumor cells:
strategies for drug therapy. Recent Pat Anticancer Drug Discov.
6:15–25. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Chen YS, Li HR, Lin M, Chen G, Xie BS, Xu
NL and Lin LF: Livin abrogates apoptosis of SPC-A1 cell by
regulating JNKI signaling pathway. Mol Biol Rep. 37:2241–2247.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Sanna MG, Duckett CS, Richter BW, Thompson
CB and Ulevitch RJ: Selective activation of JNK1 is necessary for
the anti-apoptotic activity of hILP. Proc Natl Acad Sci USA.
95:6015–6020. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Sanna MG, da Silva Correia J, Ducrey O,
Lee J, Nomoto K, Schrantz N, Deveraux QL and Ulevitch RJ: IAP
suppression of apoptosis involves distinct mechanisms: the
TAK1/JNK1 signaling cascade and caspase inhibition. Mol Cell Biol.
22:1754–1766. 2002. View Article : Google Scholar : PubMed/NCBI
|
